메뉴 건너뛰기




Volumn 100, Issue 3, 2007, Pages 488-490

A more selective approach to prostate biopsy could be a safe and effective form of prostate cancer 'prevention'

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

EID: 34547623558     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2007.07040.x     Document Type: Note
Times cited : (2)

References (8)
  • 1
    • 1542288225 scopus 로고    scopus 로고
    • American Cancer Society guidelines for the early detection of cancer
    • Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2004 54 : 41 52
    • (2004) CA Cancer J Clin , vol.54 , pp. 41-52
    • Smith, R.A.1    Cokkinides, V.2    Eyre, H.J.3
  • 2
    • 84892251112 scopus 로고    scopus 로고
    • Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA)
    • Anonymous., 277. 8, 280
    • Anonymous. Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology (Williston Park) 2000 14 : 267 72, 277 8, 280
    • (2000) Oncology (Williston Park) , vol.14 , pp. 267-72
  • 3
    • 34547623663 scopus 로고    scopus 로고
    • UK NHS. Accessed
    • UK NHS. http://www.cancerscreening.nhs.uk/prostate/prostate-patient-info- sheet.pdf. Accessed May 2007
    • (2007)
  • 4
    • 23244433208 scopus 로고    scopus 로고
    • Prostate-specific antigen levels in the United States. implications of various definitions for abnormal
    • Welch HG, Schwartz LM, Woloshin S. Prostate-specific antigen levels in the United States. implications of various definitions for abnormal. J Natl Cancer Inst 2005 97 : 1132 7
    • (2005) J Natl Cancer Inst , vol.97 , pp. 1132-7
    • Welch, H.G.1    Schwartz, L.M.2    Woloshin, S.3
  • 6
    • 33646459214 scopus 로고    scopus 로고
    • Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial
    • Thompson IM, Ankerst DP, Chi C et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst 2006 98 : 529 34
    • (2006) J Natl Cancer Inst , vol.98 , pp. 529-34
    • Thompson, I.M.1    Ankerst, D.P.2    Chi, C.3
  • 7
    • 33646827493 scopus 로고    scopus 로고
    • A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival
    • Parker C, Muston D, Melia J, Moss S, Dearnaley D. A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival. Br J Cancer 2006 94 : 1361 8
    • (2006) Br J Cancer , vol.94 , pp. 1361-8
    • Parker, C.1    Muston, D.2    Melia, J.3    Moss, S.4    Dearnaley, D.5
  • 8
    • 33747115109 scopus 로고    scopus 로고
    • Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: Utilizing all risk factors and tumor markers for prostate cancer
    • Nam RK, Toi A, Klotz LH et al. Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer. Can J Urol 2006 13 (Suppl. 2 2 10
    • (2006) Can J Urol , vol.13 , Issue.SUPPL. 2 , pp. 2-10
    • Nam, R.K.1    Toi, A.2    Klotz, L.H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.